Add BrightSurf on Google Email

Xia & He Publishing Inc.


Ganoderma lucidum alleviates high-fat diet-induced hepatic lipotoxicity via modulating the unfolded protein response and endoplasmic reticulum-phagy

This study investigates the effects of a long-term high-fat diet on lipid metabolism and hepatic lipotoxicity. Ganoderma lucidum alleviates HFD-induced liver injury by modulating the unfolded protein response (UPR) and endoplasmic reticulum-phagy, reducing serum lipids and improving cell viability in primary hepatocytes.

SourceXia & He Publishing Inc.·JournalFuture Integrative Medicine·DateOct 16, 2025

The advent of nanotechnology has ushered in a transformative era for oncology, offering unprecedented capabilities for targeted drug delivery and controlled release. This paradigm shift enhances therapeutic efficacy while mitigating the debilitating side

This review highlights the potential of nanocarriers in cancer treatment, including liposomes, solid lipid nanoparticles, polymeric nanoparticles, dendrimers, and inorganic nanoparticles. The combination of these technologies with magnetic hyperthermia and viral nanoparticles offers a promising approach to treating malignant tumors.

SourceXia & He Publishing Inc.·JournalJournal of Exploratory Research in Pharmacology·DateOct 10, 2025

Polyherbal dietary supplement MD-1 ameliorates severity of type 2 diabetes mellitus in high-fat diet-fed C57BL/6J mice by attenuating adipose tissue inflammation

This study investigates the effects of polyherbal supplement MD-1 on high-fat diet-induced diabetes in C57BL/6J mice. MD-1 treatment significantly reduces blood glucose, triacylglycerol, and total cholesterol levels, improving adipose tissue function.

SourceXia & He Publishing Inc.·JournalJournal of Exploratory Research in Pharmacology·DateOct 9, 2025

Targeting glypican-3 for liver cancer therapy

Glypican-3 is a key driver of hepatocellular carcinoma progression, facilitating metastasis and tumor microenvironment remodeling. Immunotherapy targeting GPC3 has shown preliminary safety and antitumor activity in clinical trials, with ongoing research focusing on optimized patient selection and disease monitoring.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateSep 30, 2025

Portal vein thrombosis in liver cirrhosis

Risk factors for portal vein thrombosis (PVT) in liver cirrhosis include hemodynamic disturbances, vascular endothelial injury with hypercoagulable states, severity of cirrhosis, and thrombophilic genetic factors. Early identification and timely intervention are crucial to improve prognosis.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateSep 30, 2025

ATR-FTIR spectroscopy for differentiating metaplastic breast carcinoma, ductal carcinoma in situ, and invasive ductal carcinoma

Researchers used ATR-FTIR spectroscopy to analyze tissue samples from patients with metaplastic breast carcinoma, ductal carcinoma in situ, and invasive ductal carcinoma. The study found that specific spectral features were significantly elevated in carcinomatous tissues and could effectively differentiate between normal tissue and can...

SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateSep 30, 2025

Hepatocellular carcinoma risk stratification for cirrhosis patients: Integrating radiomics and deep learning computed tomography signatures of the liver and spleen into a clinical model

A new clinical model integrating CT signatures predicts HCC risk more accurately than existing models, stratifying patients into high-risk and low-risk groups. The study enhances individualized surveillance and improves patient outcomes for cirrhosis patients.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateSep 30, 2025

Emerging serum biomarkers for chronic hepatitis B: Focus on serum HBV RNA and HBcrAg

Serum HBV RNA and HBcrAg have emerged as promising biomarkers for chronic hepatitis B, enabling better monitoring of disease progression, treatment response, and risk stratification. These markers provide a window into intrahepatic viral activity, correlating with clinical outcomes such as HCC development and liver fibrosis severity.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateSep 30, 2025

Khat-associated autoimmune hepatitis

This review synthesizes current knowledge on khat-associated autoimmune hepatitis, establishing a causal link and guiding clinical management. Khat use disrupts immune tolerance, leading to a chronic inflammatory state and the development of AIH-like phenotype in susceptible individuals.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateSep 30, 2025

Acute liver failure with determinate rather than indeterminate etiology facilitates therapy and may avoid liver transplantation

A study finds that a determinate diagnosis is crucial for initiating specific therapies in acute liver failure, potentially avoiding liver transplantation. A re-evaluation of cases initially classified as indeterminate reveals new diagnoses, including viral infections and autoimmune hepatitis.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateSep 30, 2025

Exploring the therapeutic potential of TGF-β inhibitors for liver fibrosis: targeting multiple signaling pathways

TGF-β inhibition holds promise for treating liver fibrosis by targeting SMAD-dependent and -independent pathways. Various therapeutic strategies, including direct blockade, receptor inhibitors, antisense oligonucleotides, and natural products from Traditional Chinese Medicine, are being explored to disrupt the TGF-β signaling pathway.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateSep 25, 2025

Biomarker discovery for metabolic dysfunction-associated steatotic liver disease utilizing Mendelian randomization, machine learning, and external validation

A study discovered six causal molecular biomarkers (CNPY4, ENTPD6, HLA-A) and eight clinical biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD). Serum total protein levels partially mediated the effect of HLA-A on MASLD.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateSep 25, 2025

Urinary arsenic exposure and metabolic dysfunction-associated steatotic liver disease

This study found a significant association between arsenic exposure and MASLD in humans, with higher urinary arsenic levels increasing the risk ofMASLD. The analysis also showed that arsenic exposure persisted across key subgroups, suggesting its contribution to hepatic steatosis even at moderate exposure levels.

SourceXia & He Publishing Inc.·JournalJournal of Translational Gastroenterology·DateSep 22, 2025

Achalasia treatment: A review of per-oral endoscopic myotomy and laparoscopic heller myotomy

The gut microbiome plays a crucial role in colorectal carcinogenesis, with dysbiosis promoting chronic inflammation and facilitating carcinogenesis. Probiotics, dietary interventions, and microbiome-informed immunotherapy show promise in restoring microbial balance and improving responsiveness to immunotherapy.

SourceXia & He Publishing Inc.·JournalJournal of Translational Gastroenterology·DateSep 19, 2025

Microarray analysis of differential expression of long non-coding RNAs in peripheral blood mononuclear cells in luminal a breast cancer

This study analyzed differential expression of long non-coding RNAs in peripheral blood mononuclear cells of women with luminal A breast cancer. Differential expression was observed, particularly for LINC RNA 974 (LINC00974), which exhibited significant associations with other oncological disorders.

SourceXia & He Publishing Inc.·JournalGene Expression·DateSep 15, 2025

Admission albumin-bilirubin score is inferior to MELD, MELD-Na+ and child-Turcotte-Pugh score in predicting survival in Indian patients with alcohol-associated liver disease

A study of 490 ALD patients found the ALBI score less accurate than MELD, MELD-Na+, and CTP scores in predicting survival. The ALBI score's components, such as serum albumin and bilirubin, were not independent predictors of mortality.

SourceXia & He Publishing Inc.·JournalJournal of Translational Gastroenterology·DateSep 15, 2025

Inflammasome activation as a key driver of acetaminophen-induced hepatotoxicity: Mechanisms and emerging therapeutics

Inflammasome activation plays a key role in acetaminophen-induced hepatotoxicity, triggering oxidative stress, mitochondrial dysfunction, and inflammation. Targeting inflammasome signaling offers promising therapeutic approaches, including NLRP3 inhibitors, caspase-1 inhibitors, and anti-inflammatory agents.

SourceXia & He Publishing Inc.·JournalGene Expression·DateSep 15, 2025

Multifaceted benefits of ginseng and its extracts: a brief review of immunomodulation, quality of life improvement, and antitumor potential

Ginseng exhibits multifaceted benefits through its immunomodulatory properties, improving quality of life by alleviating chronic fatigue and cognitive decline. Its extracts also show promise in inhibiting tumor growth and metastasis, suggesting potential as an adjunct therapy in oncology.

SourceXia & He Publishing Inc.·JournalFuture Integrative Medicine·DateSep 11, 2025

Decoding high-grade endometrial cancer: a molecular-histologic integration using the Cancer Genome Atlas framework

High-grade endometrial cancer (HGEC) consists of aggressive variants with poor prognosis and resistance to conventional therapies. The article proposes a molecular-histologic integration framework using the Cancer Genome Atlas to refine diagnosis, guide clinical management, and inform targeted therapy.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Pathology·DateSep 10, 2025

Global integration of traditional and modern medicine: policy developments, regulatory frameworks, and clinical integration model

The global integration of traditional and modern medicine has been shown to improve patient outcomes by enhancing symptom management, quality of life, and treatment adherence. Effective integration relies on robust regulatory frameworks governing practitioner licensing, quality control, pharmacovigilance, and research.

SourceXia & He Publishing Inc.·JournalFuture Integrative Medicine·DateSep 9, 2025

High-grade serous carcinomas identified in cervical biopsies: A clinicopathologic study supporting the exclusion of cervical serous carcinoma from World Health Organization classification

A clinicopathologic study identified high-grade serous carcinomas in cervical biopsies as secondary to upper genital tract tumors, mostly of endometrial origin. Accurate diagnosis is crucial for proper management.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Pathology·DateSep 8, 2025

Unmasking inflammatory bowel disease in nigeria: a multicenter cross-sectional analysis of clinico-pathological and endoscopic findings

This study identifies ulcerative colitis as the most common subtype of IBD in Nigeria, with rectal bleeding being the predominant clinical feature. The findings highlight significant management challenges due to high medication costs and limited availability, affecting nearly half of patients.

SourceXia & He Publishing Inc.·JournalJournal of Translational Gastroenterology·DateAug 27, 2025

Transcutaneous vagal nerve stimulation for gastrointestinal disorders

This review synthesizes evidence from clinical trials on the efficacy of transcutaneous vagal nerve stimulation (tVNS) in managing abdominal pain, improving gastrointestinal symptoms, and enhancing motility in disorders such as functional dyspepsia, gastroparesis, irritable bowel syndrome, and inflammatory bowel disease. tVNS demonstra...

SourceXia & He Publishing Inc.·JournalJournal of Translational Gastroenterology·DateAug 27, 2025

Seroprevalence 36 months after a single-dose bivalent human papillomavirus vaccination among nine to fifteen-year-old girls in Dhaka, Bangladesh

A cross-sectional study found that the bivalent HPV vaccine induces sustained immunity in Bangladeshi adolescent girls, with significant associations between HPV16/18 seropositivity and age, grade level, and household income. The overall seroprevalence was high, with 72.8% for HPV16 and 82.4% for HPV18.

SourceXia & He Publishing Inc.·JournalCancer Screening and Prevention·DateAug 27, 2025

An overview of advancements in screening methods and point-of-care diagnostics for colorectal cancer

Recent advancements in screening methods and point-of-care diagnostics offer hope for early detection and improved outcomes in colorectal cancer. Emerging technologies such as single-cell sequencing, spatial transcriptomics, and artificial intelligence are being leveraged to enhance diagnostic accuracy and personalized risk prediction.

SourceXia & He Publishing Inc.·JournalCancer Screening and Prevention·DateAug 25, 2025

The Second Beijing Consensus on Holistic Integrative Medicine for the Management of Helicobacter pylori-associated “Disease-Syndrome”

The Second Beijing Consensus provides a patient-centered approach to managing H. pylori-associated disease-syndrome, combining Western medical precision with TCM's holistic regulation. It recommends standard treatment regimens, including antibiotic therapy and TCM integration, as well as strategies for refractory cases.

SourceXia & He Publishing Inc.·JournalCancer Screening and Prevention·DateAug 25, 2025

Clinical, microbiological, and antibiotic treatment characteristics of bacterial infections in patients with liver cirrhosis in China: A multicenter study

A multicenter study in China found that patients with liver cirrhosis were prone to community-acquired pneumonia and spontaneous bacterial peritonitis, with Klebsiella pneumoniae and MDR organisms being major concerns. The study highlights the need for region-specific strategies to improve outcomes for this vulnerable population.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateAug 20, 2025

Integrated analysis of serum and fecal metabolites reveals the role of bile acid metabolism in drug-induced liver injury: Implications for diagnostic and prognostic biomarkers

Researchers identified bile acid metabolites as potential biomarkers for diagnosing and predicting drug-induced liver injury (DILI). Chenodeoxycholic acid and deoxycholic acid were found to distinguish DILI patients from healthy individuals, exhibiting predictive potential for chronicity.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateAug 20, 2025

Macromolecular gene delivery systems: Advancing non-viral therapeutics with synthetic and natural polymers

Macromolecular gene delivery systems are advancing non-viral therapeutics by overcoming challenges like lower transfection efficiency and stability issues. Innovations in polymer design, functionalization, and targeting mechanisms are paving the way for clinically viable non-viral treatments.

SourceXia & He Publishing Inc.·JournalJournal of Exploratory Research in Pharmacology·DateAug 19, 2025

Interim analysis of 48-week tenofovir amibufenamide treatment in chronic hepatitis B patients with normal alanine aminotransferase levels

A 48-week interim analysis of tenofovir amibufenamide treatment found that 74.2% of patients achieved HBV DNA levels <20 IU/mL, demonstrating a favorable safety profile. The study suggests TMF treatment as a potential therapeutic option for chronic HBV-infected patients with normal ALT levels.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateAug 19, 2025

Assessment of metabolic dysfunction-associated steatotic liver disease and liver fibrosis: A cross-sectional study in asymptomatic individuals in greater vancouver

A substantial proportion of asymptomatic individuals in Greater Vancouver have undetected MASLD and significant fibrosis. Age, male sex, ethnicity, cardiac disease, diabetes, hypertension, and obesity were significantly associated with fibrosis.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateAug 18, 2025